Atlas Trials

A Phase III Study of SP2086 in Combination With Metformin in Patients With Type 2 Diabetes

Clinical trial NCT01970046 · UNKNOWN

Trial details

NCT number
NCT01970046
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2013-04-01
Primary completion
2014-01-01
Enrollment
360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.